rs7531163

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022089.4(ATP13A2):​c.3084-3C>T variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.249 in 1,613,342 control chromosomes in the GnomAD database, including 53,206 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 4955 hom., cov: 29)
Exomes 𝑓: 0.25 ( 48251 hom. )

Consequence

ATP13A2
NM_022089.4 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.001061
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: 0.747
Variant links:
Genes affected
ATP13A2 (HGNC:30213): (ATPase cation transporting 13A2) This gene encodes a member of the P5 subfamily of ATPases which transports inorganic cations as well as other substrates. Mutations in this gene are associated with Kufor-Rakeb syndrome (KRS), also referred to as Parkinson disease 9. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 1-16986959-G-A is Benign according to our data. Variant chr1-16986959-G-A is described in ClinVar as [Benign]. Clinvar id is 128471.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-16986959-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.541 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ATP13A2NM_022089.4 linkuse as main transcriptc.3084-3C>T splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000326735.13

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ATP13A2ENST00000326735.13 linkuse as main transcriptc.3084-3C>T splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_022089.4 A1Q9NQ11-1
ENST00000446261.1 linkuse as main transcriptn.187+7847G>A intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.243
AC:
36781
AN:
151530
Hom.:
4944
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.165
Gnomad AMI
AF:
0.211
Gnomad AMR
AF:
0.338
Gnomad ASJ
AF:
0.280
Gnomad EAS
AF:
0.558
Gnomad SAS
AF:
0.244
Gnomad FIN
AF:
0.321
Gnomad MID
AF:
0.285
Gnomad NFE
AF:
0.230
Gnomad OTH
AF:
0.263
GnomAD3 exomes
AF:
0.282
AC:
70700
AN:
250814
Hom.:
11144
AF XY:
0.277
AC XY:
37663
AN XY:
135760
show subpopulations
Gnomad AFR exome
AF:
0.171
Gnomad AMR exome
AF:
0.360
Gnomad ASJ exome
AF:
0.264
Gnomad EAS exome
AF:
0.551
Gnomad SAS exome
AF:
0.231
Gnomad FIN exome
AF:
0.317
Gnomad NFE exome
AF:
0.239
Gnomad OTH exome
AF:
0.283
GnomAD4 exome
AF:
0.250
AC:
365088
AN:
1461694
Hom.:
48251
Cov.:
66
AF XY:
0.249
AC XY:
181231
AN XY:
727176
show subpopulations
Gnomad4 AFR exome
AF:
0.166
Gnomad4 AMR exome
AF:
0.356
Gnomad4 ASJ exome
AF:
0.263
Gnomad4 EAS exome
AF:
0.534
Gnomad4 SAS exome
AF:
0.236
Gnomad4 FIN exome
AF:
0.310
Gnomad4 NFE exome
AF:
0.235
Gnomad4 OTH exome
AF:
0.262
GnomAD4 genome
AF:
0.243
AC:
36817
AN:
151648
Hom.:
4955
Cov.:
29
AF XY:
0.251
AC XY:
18579
AN XY:
74050
show subpopulations
Gnomad4 AFR
AF:
0.166
Gnomad4 AMR
AF:
0.338
Gnomad4 ASJ
AF:
0.280
Gnomad4 EAS
AF:
0.558
Gnomad4 SAS
AF:
0.244
Gnomad4 FIN
AF:
0.321
Gnomad4 NFE
AF:
0.230
Gnomad4 OTH
AF:
0.262
Alfa
AF:
0.235
Hom.:
2234
Bravo
AF:
0.244
Asia WGS
AF:
0.363
AC:
1262
AN:
3478
EpiCase
AF:
0.246
EpiControl
AF:
0.249

ClinVar

Significance: Benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoAug 15, 2013- -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJul 15, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 47% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 44. Only high quality variants are reported. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Kufor-Rakeb syndrome Benign:3
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxJul 05, 2018- -
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicDec 16, 2015- -
Autosomal recessive spastic paraplegia type 78 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Kufor-Rakeb syndrome;C5567893:Autosomal recessive spastic paraplegia type 78 Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 24, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
7.0
DANN
Benign
0.71

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0011
dbscSNV1_RF
Benign
0.10
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs7531163; hg19: chr1-17313454; COSMIC: COSV104399909; COSMIC: COSV104399909; API